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Introduction
Hepatic artery thrombosis (HAT) after orthotopic liver trans-
plantation (OLT) remains a life-threatening complication.
Although a few patients survive without symptoms, most
patients with HAT experience serious morbidity, and the
mortality rate is high. Treatment of HAT usually requires
surgical intervention, with retransplantation considered the
standard therapy.1 However, retransplantation is limited by
both organ availability and the patient’s condition. Urgent
revascularization with thrombectomy and a combination of
thrombectomy with revision of anastomosis has been success-
ful in some patients with an early diagnosis.2–5 A number of
patients with delayed HAT are not immediately diagnosed,
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and surgical revascularization in these patients does not give
good results because of condensed adhesion around and or-
ganization of clots in the vessel.6 Conservative treatment is
often adopted to prepare these patients for retransplantation.
The aim of this study was to evaluate conservative treatment
as definitive therapy for HAT.
Patients and methods
Between October 1991 and July 2002, 248 OLTs were per-
formed in 237 patients at Queen Mary Hospital, Hong Kong:
108 whole-graft OLTs and 140 live donor liver transplants
(LDLTs). In whole-graft OLT, the donor coeliac artery was
anastomosed to the junction of the gastroduodenal artery and
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patients. Among the six patients, three had received whole-graft OLT and three had received right-lobe LDLT.
Treatment included retransplantation, thrombectomy plus thrombolysis, and conservative treatment of hepatic
and biliary complications.
RESULTS: Five patients survived after treatment. Among the three LDLT recipients who received conservative
treatment, two had subsequent collateral formation and one had spontaneous recanalization of arterial inflow.
Of the three recipients of whole-graft OLT, the first died because of hepatic failure and technically difficult
retransplantation, the second had thrombectomy plus thrombolysis but had recurrence of thrombosis that
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hepatic artery thrombosis. Collateralization is more likely to develop after LDLT than after whole-graft OLT.
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common hepatic artery. For LDLT, a microvascular technique
was employed to anastomose the donor artery to either the
right or left hepatic artery. No preventive anticoagulant was
used postoperatively. Of 13 patients who had previously un-
dergone transarterial oily chemoembolization (TOCE), five
received whole-graft OLT and eight received LDLT. Seven
episodes of HAT were identified in six patients. HAT was
confirmed using Doppler ultrasonography and angiography
in all cases. Anticoagulant was not given during conservative
treatment.
Results
Details of the patients with HAT are shown in the Table. Six
patients developed HAT. Patient 4 had two episodes of HAT.
Thus, four HAT episodes occurred after whole-graft OLT and
three after LDLT (Table). Two of the eight LDLT recipients
(25%) who had previously undergone TOCE developed HAT,
while HAT occurred in only one of the 105 LDLT recipients
(1%) who had not previously had TOCE (Chi-squared test,
16.634; p = 0.013). In the whole-graft OLT group, there was
no significant difference between patients with and without
previous TOCE (0/5 vs 3/103). Before the diagnosis was
confirmed, all patients had impaired liver function and vari-
ous symptoms, except Patient 4, who was asymptomatic dur-
ing the two episodes of HAT. Two patients were diagnosed
early (Patients 4 and 6) after whole-graft OLT. Both received
urgent laparotomy. One (Patient 4) was treated successfully
using thrombectomy plus intra-arterial injection of urokinase.
After 43 days, however, this patient had recurrent HAT and
was treated conservatively. Patient 6 had multiple hepatic
necroses and organized clots in the hepatic artery, which were
not amenable to recannulation. The patient recovered after
retransplantation.
The remaining four patients (Patients 1–3 and 5) had
delayed HAT diagnosed between postoperative Day 21 and
105. Patient 1, who was confirmed with HAT on Day 105 after
whole-graft OLT, had incomplete collateral formation at the
hepatic hilum shown by angiography (Figure 1). Urgent re-
transplantation was attempted owing to hepatic failure, but
it was not successful because of difficult dissection and mas-
sive bleeding. The patient died soon after the operation. Pa-
tients 2, 3 and 5, who had received LDLT, presented with one
or more morbidities when the diagnosis was confirmed. They
were treated using percutaneous drainage of the biloma and
abscess, dilatation of the biliary tract and systemic antibiotics.
The symptoms were gradually alleviated and liver function
improved. Two (Patients 2 and 3) had been placed on the
waiting lists for retransplantation. However, after 38 and 85
days of treatment, respectively, revascularization with
collaterals was detected by Doppler ultrasonography and an-
giography (Figure 2). Retransplantation was considered un-
necessary and the patients recovered with normal liver func-
tion after 124 and 156 days of conservative treatment,
respectively. Patient 5 underwent many episodes of hepatic
and biliary complications. Multiple procedures were
undertaken. After long-term (6 months) conservative
treatment, spontaneous recanalization of the hepatic artery
was detected by both Doppler ultrasonography and enhanced
computerized tomography (CT) scan and the patient’s situa-
tion was much improved.
Discussion
Revascularization is essential for salvage of the graft after HAT.
One report showed that collaterals were formed as early as 2
weeks after transplantation.7 The sources of collateralization
are thought to be the intrahepatic left or right hepatic artery,
superior mesenteric artery, splenic artery, inferior phrenic artery,
left gastric artery and the arteries of the omentum and Roux-
en-Y limb.7–10 Complete revascularization was found in four of
the five patients with delayed HAT out of the seven HAT
episodes in our study. Interestingly, three of these were LDLT
recipients while only one was a whole graft recipient. The other
delayed HAT after whole-graft OLT had incomplete collaterals.
This result is compatible with the report that reduced-size
grafts were more likely to form arterial collaterals.4 Wozney
et al reported that 43% of paediatric arterial occlusions after
OLT developed collaterals while no collaterals were observed in
adults.7 The difference in collateralization between adults and
children may be due partially to the different surgical methods
adopted, as children received reduced-size grafts more fre-
quently than adults in Wozney et al’s series. The possible
mechanism of the prevalence of collateralization in reduced-
size graft or LDLT is that the arterioles at the liver transection
surface act as conduits for collateral vessel regeneration.11
Another possibility is that the tissues around the coeliac
branches in LDLT are intact compared to those in whole-graft
OLT, and the length of donor artery is much shorter in LDLT
than in whole-graft OLT. Collaterals are more probably and
rapidly established across the anastomosis if the tissues sur-
rounding the artery are intact and the length of donor hepatic
artery from the anastomosis to the liver hilum is short.
There is no established treatment of choice for delayed
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Table. Data of six patients with hepatic artery thrombosis (HAT)
Patient OLT Gender/ Preoperative Previous Presentation Occurrence Treatment Outcome Outcome
No. age (yr) diagnosis TOCE Graft at time HAT after for HAT of hepatic of patient
confirmed OLT (d) artery
1 94 M/48 Hepatitis B No Whole Deranged 105 Dilatation No Died
cirrhosis LFT, fever, and stent change
epigastric insertion at
pain, strictured
graft bile duct
failure anastomosis,
systemic
antibiotics,
failed
re-OLT
2 171 F/63 Hepatitis B 2 sessions Right Deranged 21 Drainage of Revascu- Asymp-
cirrhosis, lobe LFT, RFT, biloma, larized tomatic
HCC LDLT fever, systemic by collater- with
septic antibiotics alization normal
shock LFT and
RFT
3 126 M/47 Fulminant No Right Deranged 102 Drainage of Revascu- Asymp-
hepatic lobe LFT, fever, abscess, larized tomatic
failure LDLT septic dilatation of by collater- with
shock, strictured HJ alization normal
hypogly- anastomosis, LFT
caemia, PTBD,
hepatic systemic
abscess antibiotics
4 177 M/49 Hepatitis B No Whole Deranged 9 Thrombec- Recurrent Asymp-
cirrhosis LFT tomy and HAT with tomatic
intra-arterial deranged with
injection of LFT, spon- normal
urokinase taneous LFT
recanali-
zation
5 213 M/47 Hepatitis B 1 session Right Deranged 24 Drainage of Spon- Generally
cirrhosis, lobe LFT, abscess, taneous stable,
recurrent LDLT hepatic dilatation recanali- intermit-
HCC abscess, and stent zation tent fever
after right stricture insertion at due to
posterior of bile bile duct intra-
hepatec- duct ana- stricture, hepatic
tomy stomosis endoscopic bile duct
sludge stricture
clearance,
systemic
antibiotics
6 221 M/26 Wilson’s No Whole Deranged 2 Failed throm- Patent Asymp-
disease, LFT, fever, bectomy, tomatic
3rd OLT graft systemic with
for failure antibiotics, normal
rejection re-OLT LFT
OLT = orthotopic liver transplantation; TOCE = transarterial oily chemoembolization; LFT = liver function test; HCC = hepatocellular
carcinoma; LDLT = live donor liver transplantation; RFT = renal function test; HJ = hepaticojejunostomy; PTBD = percutaneous transhepatic
biliary drainage.
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HAT. Retransplantation is considered the treatment of choice
but is not always suitable. Complicated biliary sepsis and
difficult dissection during explantation are the major risk
factors for operative failure. If extensive perihepatic collaterals
have developed in these patients, retransplantation will be met
with much more bleeding than the initial OLT.9 Bhattacharjya
et al reported that five of 16 patients with delayed HAT who
received retransplantation died within 6 months; one died
during surgery.6 The failure of retransplantation in one of
our patients was also ascribed to condensed adhesion and
multiple collaterals at the hepatic hilum, which led to difficult
dissection and massive bleeding. Thrombectomy is also diffi-
cult as the organized clots may closely adhere to the vessel
wall in the lumen.6 Therefore, conservative treatment be-
comes the only choice in some of these patients. The most
common complications secondary to HAT are hepatic abscess,
biliary stricture and septicaemia. Treatment of these compli-
cations requires prolonged and multiple procedures because
liquefaction of the infarcted necrosis is a gradual process,
biloma from leakage of intrahepatic bile duct necrosis needs
continuous drainage until bile leakage stops, and biliary
stricture often appears later than the other complications12
and requires multiple dilatations and stent placements,
and may lead to subsequent sludge and stone formation. CT-
or ultrasound-guided drainage of the hepatic abscesses
in these patients has given good results.13 Good long-term
results have also been obtained in 62.5% to 72% of patients
with benign biliary strictures by dilatation and stent place-
ment through the endoscopic or percutaneous transhepatic
route.14,15 In our practice, a combination of these methods
with potent systemic antibiotics solved post-HAT pro-
blems one by one, and the grafts were therefore salvaged in
four of the five delayed HATs without the need for repeat
surgery. Although we treated only a small number of patients,
we believe that conservative treatment for delayed HAT after
LDLT is the best choice if each of the complications is effec-
tively managed with patience, provided that the patient has no
hepatic failure.
Even though investigation of the risk factors for HAT was
not the aim of this study, we are interested in discussing the
role of TOCE in the development of post-transplant HAT.
Richard et al reported that there is no significant difference in
HAT incidence between patients with and without preoperative
TOCE.16 However, we found that there was a significantly
higher incidence of HAT in patients with preoperative TOCE
if they received LDLT, although there was no difference in the
whole-graft OLT group. It is obvious that the portion of the
artery to which the tip of the TOCE catheter reaches is more
likely to be damaged, for the drug concentration is highest
there. Emboli and foreign body giant cell reaction have been
identified within the walls of the branches of the hepatic artery
after TOCE.17 The use of such a portion or more distal branches
for anastomosis with the graft’s artery may lead to stenosis or
thrombus formation. During LDLT, the right or left branch of
the hepatic artery is frequently used for anastomosis, while the
proximal portion of the hepatic artery, which is less affected by
TOCE, is used in whole-graft OLT. This may explain the
difference in HAT incidence after TOCE in both groups. For
patients with previous TOCE who need LDLT, we suggest that
transplant surgeons should be aware of the previous TOCE
and select another branch such as the gastroduodenal artery
for anastomosis.
Figure 1. Superior mesenteric arteriogram demonstrating incom-
plete collaterals at the hepatic hilum.
Figure 2. Coeliac arteriogram demonstrating bridging collaterals
between the gastroduodenal artery and hepatic artery distal to the
thrombosis.
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